296 related articles for article (PubMed ID: 37635935)
1. Glutamine metabolic reprogramming in hepatocellular carcinoma.
Ye Y; Yu B; Wang H; Yi F
Front Mol Biosci; 2023; 10():1242059. PubMed ID: 37635935
[TBL] [Abstract][Full Text] [Related]
2. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Zhang Q; Wei T; Jin W; Yan L; Shi L; Zhu S; Bai Y; Zeng Y; Yin Z; Yang J; Zhang W; Wu M; Zhang Y; Peng G; Roessler S; Liu L
J Hepatol; 2024 Feb; 80(2):293-308. PubMed ID: 38450598
[TBL] [Abstract][Full Text] [Related]
4. AGC1-mediated Metabolic Reprogramming and Autophagy Sustain Survival of Hepatocellular Carcinoma Cells under Glutamine Deprivation.
Liu Y; Miao Z; Yang Q
Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38789662
[TBL] [Abstract][Full Text] [Related]
5. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
6. Metformin-Loaded Hyaluronic Acid-Derived Carbon Dots for Targeted Therapy against Hepatocellular Carcinoma by Glutamine Metabolic Reprogramming.
Ghosh A; Ghosh AK; Zaman A; Das PK
Mol Pharm; 2023 Dec; 20(12):6391-6406. PubMed ID: 37933877
[TBL] [Abstract][Full Text] [Related]
7. Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma.
Ziki RA; Colnot S
JHEP Rep; 2024 May; 6(5):101077. PubMed ID: 38699532
[TBL] [Abstract][Full Text] [Related]
8. SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis.
Xu K; Ding J; Zhou L; Li D; Luo J; Wang W; Shang M; Lin B; Zhou L; Zheng S
Cells; 2022 Dec; 12(1):. PubMed ID: 36611819
[TBL] [Abstract][Full Text] [Related]
9. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment.
Yang C; Lee D; Zhang MS; Tse AP; Wei L; Bao MH; Wong BP; Chan CY; Yuen VW; Chen Y; Wong CC
Adv Sci (Weinh); 2022 Dec; 9(34):e2202104. PubMed ID: 36310121
[TBL] [Abstract][Full Text] [Related]
11. Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma.
Tang L; Zeng J; Geng P; Fang C; Wang Y; Sun M; Wang C; Wang J; Yin P; Hu C; Guo L; Yu J; Gao P; Li E; Zhuang Z; Xu G; Liu Y
Clin Cancer Res; 2018 Jan; 24(2):474-485. PubMed ID: 29084919
[No Abstract] [Full Text] [Related]
12. Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism.
Soukupova J; Malfettone A; Hyroššová P; Hernández-Alvarez MI; Peñuelas-Haro I; Bertran E; Junza A; Capellades J; Giannelli G; Yanes O; Zorzano A; Perales JC; Fabregat I
Sci Rep; 2017 Oct; 7(1):12486. PubMed ID: 28970582
[TBL] [Abstract][Full Text] [Related]
13. PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC.
Kim MJ; Choi YK; Park SY; Jang SY; Lee JY; Ham HJ; Kim BG; Jeon HJ; Kim JH; Kim JG; Lee IK; Park KG
Mol Cancer Res; 2017 Sep; 15(9):1230-1242. PubMed ID: 28584024
[TBL] [Abstract][Full Text] [Related]
14. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.
Hoerner CR; Chen VJ; Fan AC
Kidney Cancer; 2019 Feb; 3(1):15-29. PubMed ID: 30854496
[TBL] [Abstract][Full Text] [Related]
15. Glutamine Is Required for M1-like Polarization of Macrophages in Response to Mycobacterium tuberculosis Infection.
Jiang Q; Qiu Y; Kurland IJ; Drlica K; Subbian S; Tyagi S; Shi L
mBio; 2022 Aug; 13(4):e0127422. PubMed ID: 35762591
[TBL] [Abstract][Full Text] [Related]
16. A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.
Zhu Y; Li T; Ramos da Silva S; Lee JJ; Lu C; Eoh H; Jung JU; Gao SJ
mBio; 2017 Aug; 8(4):. PubMed ID: 28811348
[TBL] [Abstract][Full Text] [Related]
17. Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma.
Wei D; Chen D; Mou H; Chakraborty S; Wei B; Tan L; Lorenzi PL; Qian X; Yang P
Mol Cancer Ther; 2023 Jun; 22(6):693-705. PubMed ID: 36780187
[TBL] [Abstract][Full Text] [Related]
18. Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress.
Hu C; Xin Z; Sun X; Hu Y; Zhang C; Yan R; Wang Y; Lu M; Huang J; Du X; Xing B; Liu X
J Exp Clin Cancer Res; 2023 May; 42(1):108. PubMed ID: 37122003
[TBL] [Abstract][Full Text] [Related]
19. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Sun J; Ding J; Shen Q; Wang X; Wang M; Huang Y; Zhang X; Zhu H; Zhang F; Wu D; Peng M; Zhang Z; Yuan Y; Li W; She ZG; Zhang XJ; Li H; Zhang P; Huang Z
J Hepatol; 2023 Mar; 78(3):627-642. PubMed ID: 36462680
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development.
Serra M; Di Matteo M; Serneels J; Pal R; Cafarello ST; Lanza M; Sanchez-Martin C; Evert M; Castegna A; Calvisi DF; Mazzone M; Columbano A
Cell Mol Gastroenterol Hepatol; 2022; 14(3):609-624. PubMed ID: 35714859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]